WebJul 3, 2024 · Inadequately controlled moderate to severe asthma Protocol Number CCJM112X2204 Protocol Title A randomized, subject- and investigator-blinded, placebo … WebAug 7, 2024 · The purpose of this study was to determine if CJM112, an anti-IL-17A antibody, displayed the clinical efficacy and safety profile to support further development in patients with inadequately controlled moderate to severe asthma with low IgE and low circulating eosinophil levels.
First-in-human study demonstrating the safety and clinical ... - PubMed
WebThe purpose of this study was to determine if CJM112, an anti-IL-17A antibody, displayed the clinical efficacy and safety profile to support further development in patients with … WebMay 1, 2024 · Currently, CJM112, an IL-17A antibody, is being evaluated in a phase 2a study of adults with moderate-to-severe, poorly controlled asthma who have a blood eosinophil level of less than 300 cells/μL and total serum IgE level less than 150 IU/mL (NCT03299686); the results of that study are expected toward the end of 2024. is frost forecast
CJM112 - Home - ClinicalTrials.gov
WebKód ZP Názov Doplnok Kód výrobcu; Kód ZP A 0176A: Názov Roztok na ošetrenie ústnej dutiny Mucocyn: Doplnok 1000ml, pri stomatologických infekciách, vyplachovanie rezných rán v ústnej dutine: Kód výrobcu OCM: Kód ZP A 0169A: Názov Roztok dermálny irigačný Microdacyn60 Wound Care: Doplnok 100ml; na výplach a vlhčenie rán: Kód výrobcu … WebApr 20, 2015 · This is a randomized, double blind, multicenter study in patients with moderate to severe chronic hidradenitis suppurativa in parallel groups, to determine the efficacy and safety of multiple doses of CJM112 in comparison to placebo. The study has two periods to explore preliminary dose effects. WebDec 20, 2016 · The study was designed primarily to assess preliminary efficacy and safety of CJM112 in patients with moderate to severe inflammatory acne and to determine if CJM112 has an adequate clinical profile for further clinical development. In addition, sustainability of response and dose relationship were to be explored. s2khe3_a/h